Diagnostic accuracy and prognostic value of CMR in patients with suspected acute coronary syndrome: a meta-analysis

Authors:

Abstract
Aims: Cardiovascular magnetic resonance (CMR) could be considered as first diagnostic test in patients with suspected non-ST-elevation acute coronary syndrome (NSTE-ACS), since up to one-third do not have obstructive coronary artery disease (CAD). This meta-analysis aimed to investigate (i) the diagnostic accuracy of CMR to detect obstructive CAD and NSTE-ACS, and (ii) the prognostic value of CMR in patients with suspected NSTE-ACS. Methods and results: Pubmed, Embase, and Cochrane Library were searched (30 November 2024) for eligible studies. To determine the diagnostic accuracy of CMR prior to invasive coronary angiography, sensitivity, specificity, and likelihood ratios (LR+/−) were calculated for each endpoint. Data were pooled using a bivariate random-effects model. This meta-analysis was pre-registered in PROSPERO (CRD42024625306). Sixteen studies with 1386 patients were included. The pooled sensitivity and specificity to detect obstructive CAD (eight studies) were 85% (95%CI 78–91%) and 73% (95%CI 57–85%). The pooled LR+ and LR− were 3.20 (95%CI 1.78–5.73) and 0.20 (95%CI 0.11–0.36). The pooled sensitivity and specificity to diagnose NSTE-ACS (five studies) were 83% (95%CI 73–89%) and 89% (95%CI 72–96%). The pooled LR+ and LR− were 7.45 (95%CI 2.77–20.02) and 0.20 (95%CI 0.13–0.30). Finally, the pooled sensitivity and specificity for prognosis based on ACS-related outcomes (four studies) were 98% (95%CI 42–100%) and 85% (95%CI 65–95). The pooled LR+ and LR− were 6.55 (95%CI 2.45–17.54) and 0.03 (95%CI 0–1.54). Conclusion: CMR can detect obstructive CAD and diagnose NSTE-ACS with excellent pooled sensitivity and specificity. CMR findings are strongly associated with clinical outcome in patients with suspected NSTE-ACS.
Funding Information
  • Academic Alliance Fund
  • Maastricht UMC+
  • Radboud UMC

This publication has 39 references indexed in Scilit: